10 Key Players Revolutionizing the Medical Devices Market in 2024

10 Key Players Revolutionizing the Medical Devices Market in 2024

date

Dec 2, 2024

Blog Med Devices & Surgical 10 Key Players Revolutionizing the Medical Devices Market in 2024

In today’s fast-paced world, the medical devices market has emerged as a cornerstone of healthcare, transforming how diseases are diagnosed, treated, and managed. From wearable technology that monitors our vitals to robotic systems that assist in complex surgeries, these devices are reshaping the medical field. Behind this transformation are companies tirelessly innovating to enhance patient outcomes and create a healthier future.

Here, we explore the leading players driving this transition, their latest innovations, and real-world examples of their impact.

According to BCC Research, the medical devices market is set to grow substantially. The market size was $739.6 billion in 2023 and is expected to increase from $810.4 billion in 2024 to an impressive $1.3 trillion by 2029, with a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029. This growth is being driven by advances in medical technology, rising demand for innovative healthcare solutions, the rising prevalence of chronic diseases, and a global emphasis on patient-centered care.

Picture1-Dec-02-2024-11-58-29-4855-AM

 

Medical Devices: Technologies and Global Markets

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Key players in the medical devices industry

  1. Medtronic (1949, Ireland)

Medtronic focuses on medical technologies for cardiac and vascular diseases, diabetes management, and neurological disorders. The corporation, which operates in over 150 countries, reported revenue of $31.2 billion in 2023. Their recent innovation includes the MiniMed™ 780G system, an advanced insulin pump with automated insulin delivery that enhances diabetes management.

Example: A clinical investigation found that patients using the MiniMed™ 780G device experienced improved glycemic control by lowering HbA1c levels and time spent in hypoglycemia.

  1. Johnson & Johnson (Ethicon) (1949, USA)

Ethicon, a subsidiary of Johnson & Johnson, specializes in surgical innovations such as wound closure, biosurgery, and energy-based surgical devices. The company operates in more than 60 countries. Their recent innovation is the ECHELON FLEX™ GST System, a powered stapler designed to provide consistent staple formation across different tissue thicknesses, improving surgical outcomes.

Example: In colorectal surgeries, the ECHELON FLEX™ GST System showed a decrease in anastomotic leak rates, leading to enhanced patient recovery.

  1. Philips Healthcare (1891, Netherlands)

Philips Healthcare focuses on diagnostic imaging, patient monitoring, and health informatics. Operating in over 100 countries, Philips generated approximately 18.2 billion euros in revenue. The company’s recent innovations include Philips Lumify, a portable ultrasound solution that turns smart devices into ultrasound systems, improving accessibility.

Example: In remote areas, healthcare providers utilize Philips Lumify to perform point-of-care ultrasounds, which leads to faster diagnosis and treatment decisions.

  1. Siemens Healthineers (2015, Germany)

Siemens Healthineers is focused on medical imaging, laboratory diagnostics, and innovative therapies. With operations in more than 70 countries, Siemens Healthineers recorded a revenue of approximately 21.7 billion euros in the fiscal year 2023. Their recent innovation is the ARTIS icono, a highly flexible angiography system that supports a wide range of minimally invasive procedures.

Example: Hospitals who used the ARTIS icono system reported improved procedural efficiency and image quality during interventional radiology treatments.

  1. GE Healthcare (2023, USA)

GE Healthcare specializes in medical imaging, monitoring, biomanufacturing as well as cell and gene therapy technologies. The company operates in more than 160 countries and reported revenue of $19.6 billion in 2023. Their most recent innovation is the Revolution Apex CT system, which offers high-resolution imaging while reducing radiation exposure.

Example: Clinics utilizing the Revolution Apex CT scanner observed enhanced diagnostic accuracy in detecting cardiovascular diseases.

  1. Abbott Laboratories (1894, USA)

Abbott specializes in diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. It operates in over 160 countries and reported a revenue of $19.6 billion in 2023 in the medical device segment. Their most recent innovation is the FreeStyle Libre 3, a continuous glucose monitoring system with a small, discreet sensor that provides real-time glucose measurements.

Example: Patients who used FreeStyle Libre 3 reported better glucose management and higher satisfaction due to the system's ease of use and accuracy.

  1. Boston Scientific (1979, USA)

Boston Scientific develops devices for interventional medical specialties, such as cardiology, endoscopy, and urology. With operations in more than 100 countries, the company recorded a revenue of $14.24 billion in 2023. Their recent innovation is the WATCHMAN FLX™ Left Atrial Appendage Closure Device, which is designed to reduce the risk of stroke in patients with non-valvular atrial fibrillation.

Example: Clinical studies have shown that the WATCHMAN FLX™ device effectively reduces the incidence of stroke, offering a viable alternative to long-term anticoagulation therapy.

  1. Stryker (1941, USA)

Stryker focuses on orthopedic implants, surgical equipment, neurotechnology, and spinal devices. They operate in more than 100 countries and reported a revenue of $20.5 billion in 2023. The Mako SmartRobotics™ system is a recent innovation that combines robotic-arm assistance with 3D CT-based planning for joint replacement surgeries.

Example: Surgeons who used the Mako system reported higher implant placement precision, which resulted in better patient outcomes and faster recovery times.

  1. Zimmer Biomet (1927, USA)

Zimmer Biomet specializes in musculoskeletal healthcare and provides orthopedic reconstructive products and surgical solutions. It claimed $7.39 billion in revenue in 2023, with operations in more than 40 countries and sales in over 100 countries. The ROSA® Knee System, a robotic surgical assistant for knee replacement treatments, is its most recent innovation, improving surgical accuracy.

Example: Hospitals that used the ROSA® Knee System reported lower variability in surgery outcomes and improved patient satisfaction.

  1. Becton, Dickinson and Company (BD) (1897, USA)

BD manufactures medical devices, laboratory equipment, and diagnostic products. The corporation operates in over 190 countries and reported $19.4 billion in revenue for 2023. The BD Veritor™ Plus System is a portable device that detects infectious diseases quickly and reliably.

Example: During the COVID-19 pandemic, the BD Veritor™ Plus System helped healthcare facilities undertake quick testing, leading to timely isolation and treatment.

Conclusion

The medical devices market is a powerhouse of innovation, transforming the way we approach healthcare. With a projected $1.3 trillion in revenue by 2029, the industry is positioned to alter global health on an unprecedented scale. Companies such as Medtronic, Johnson & Johnson, Philips, and others are leading the way with groundbreaking innovations and real-world impact. As these advances continue, the future of healthcare promises to provide greater precision, accessibility, and better outcomes for patients globally.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.

    Stay ahead of industry trends, build your market research strategy and more.

    Karishma Arora

    Written By Karishma Arora

    Karishma Arora is an Assistant Team Lead in Marketing Operations at BCC Research, with a master's degree in commerce. She is a passionate marketer with a knack for creativity and data-driven strategies.

    Guiding smart decisions every step of the way

    Guiding smart decisions every step of the way

    We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.

    Contact Us